Cancers are classified into several major types based on the tissue or cell type where they originate. The five broad categories are carcinomas, sarcomas, leukemias, lymphomas, and myelomas. Within those groups, there are hundreds of specific subtypes, but understanding the main categories gives you a solid framework for making sense of any cancer diagnosis.
Carcinomas: The Most Common Type
Carcinomas start in epithelial cells, the cells that line the surfaces of your skin, organs, and glands. This category accounts for the vast majority of cancer diagnoses. It splits into two major subtypes.
Adenocarcinomas develop in organs or glands, typically starting in mucus membranes. They tend to spread easily through the soft tissue around them. Most breast, colon, prostate, pancreatic, and lung cancers are adenocarcinomas.
Squamous cell carcinomas originate in the flat cells that make up the outer layers of skin and the linings of organs like the lungs, throat, and esophagus. They occur in many areas of the body, and skin squamous cell carcinoma is one of the most frequently diagnosed cancers overall.
Other carcinoma subtypes include basal cell carcinoma (the most common skin cancer, which grows slowly and rarely spreads) and transitional cell carcinoma, which forms in the stretchy lining of organs like the bladder.
Sarcomas: Cancers of Bone and Soft Tissue
Sarcomas arise in connective tissues: bones, muscles, cartilage, fat, blood vessels, or tendons. They are far less common than carcinomas but can occur almost anywhere in the body. The specific subtype depends on which tissue is involved.
- Osteosarcoma develops from the cells that create bone and is most common in teenagers and young adults.
- Chondrosarcoma develops from cartilage cells, often in the pelvis, legs, or arms.
- Leiomyosarcoma arises from smooth muscle, frequently within blood vessels of the limbs, abdomen, or pelvis.
Soft tissue sarcomas can also form in fat (liposarcoma) or fibrous tissue (fibrosarcoma). Because they grow in supportive structures rather than organ linings, sarcomas often feel like a firm, deep mass rather than a surface-level lump.
Blood and Immune System Cancers
Three major cancer types originate in blood-forming tissues or immune cells. They behave differently from solid tumors because the cancerous cells circulate through the body or cluster in immune tissue rather than forming a single mass.
Leukemia involves cancerous white blood cells circulating in the blood and bone marrow. It can arise from either of the two main white blood cell families: lymphocytes or myelocytes. Because leukemia cells travel through the bloodstream from the start, it doesn’t follow the same “stages” as solid tumors. There are both acute (fast-growing) and chronic (slower-growing) forms.
Lymphoma also involves lymphocytes, but instead of circulating freely, the cancerous cells tend to cluster and form tumors in lymphatic tissues like lymph nodes, the spleen, or the tonsils. The two main forms are Hodgkin lymphoma and non-Hodgkin lymphoma, which differ in the specific type of immune cell involved and how the disease progresses.
Myeloma (often called multiple myeloma) is a cancer of plasma cells in the bone marrow. Plasma cells are specialized white blood cells that normally produce antibodies. When they become cancerous, they crowd out healthy blood cells and produce an abnormal protein that can damage bones and kidneys.
Brain and Spinal Cord Tumors
Central nervous system cancers don’t fit neatly into the categories above because they arise from the specialized cells of the brain and spinal cord rather than epithelial cells, connective tissue, or blood cells. Gliomas, which start in the supportive glial cells of the brain, are the most common type. Others include meningiomas (in the membranes surrounding the brain) and medulloblastomas, which are more common in children. Brain tumors are graded on a scale of 1 to 4 based on how abnormal the cells look and how quickly they grow, with grade 4 being the most aggressive.
The Most Commonly Diagnosed Cancers
Globally, lung cancer is the single most frequently diagnosed cancer, with 2.5 million new cases per year, representing 12.4% of all new cancer diagnoses. Female breast cancer ranks second at 2.3 million cases (11.6%), followed by colorectal cancer at 1.9 million (9.6%), prostate cancer at 1.5 million (7.3%), and stomach cancer at 970,000 cases (4.9%). These five cancers together account for nearly half of all new diagnoses worldwide.
Patterns shift with age. In children under 14, the most common cancers are leukemias, brain and spinal cord tumors, and lymphomas. Adult cancers typically reflect decades of accumulated DNA damage from aging and environmental exposures, while childhood cancers arise from gene mutations that occur early in development.
Rare Cancers
A cancer is classified as rare when it affects fewer than 40,000 people per year in the United States. This includes rare bone tumors, rare endocrine tumors, and rare digestive system tumors, among others. Individually each type is uncommon, but collectively rare cancers account for a significant share of all diagnoses. They can be harder to study and treat because fewer patients means smaller clinical trials and less data on which therapies work best.
What Makes a Cancer Malignant
Not every tumor is cancer. Benign tumors are localized growths that don’t invade nearby tissue or spread to other parts of the body. They’re rarely life-threatening. Malignant tumors, by contrast, can invade surrounding tissue and send cells through the bloodstream or lymphatic system to establish new tumors (metastases) in distant organs. Cancerous tumors also tend to feel firmer and less movable under the skin than benign lumps or cysts.
Between benign and malignant, there’s a middle stage. Precancerous cells divide faster than normal (a process called hyperplasia) and may look abnormal under a microscope (dysplasia). Not all precancerous changes become cancer, but they’re often monitored or removed to reduce risk.
How Cancers Are Staged
Once a cancer is identified by type, it’s staged to describe how far it has spread. The TNM system is the most widely used method in hospitals worldwide. It evaluates three things: the size of the primary tumor (T), whether cancer has reached nearby lymph nodes (N), and whether it has metastasized to distant parts of the body (M). Each letter is followed by a number. Higher numbers mean a larger tumor, more affected lymph nodes, or confirmed spread. A designation of T2N1M0, for example, describes a moderate-sized tumor that has reached one area of nearby lymph nodes but has not spread to distant organs.
Staging matters because it directly shapes treatment decisions and gives a clearer picture of prognosis. A stage I cancer caught early in a single location is a very different situation from a stage IV cancer that has spread to multiple organs.
Inherited vs. Random Mutations
Up to 10% of all cancers are caused by inherited genetic changes passed from parent to child. The BRCA mutations linked to breast and ovarian cancer are a well-known example. But the vast majority of cancers develop from random mistakes that accumulate as cells divide over a lifetime, or from DNA damage caused by carcinogens like tobacco smoke, UV radiation, or certain chemicals. This is why cancer risk increases with age: more years means more opportunities for errors to pile up in your DNA.